The Metabolic Effects of Empagliflozin in Patients With High Risk of Heart Failure
Clinical trial NCT05042973 · COMPLETED
Trial details
- NCT number
- NCT05042973
- Sponsor
- Jacob Moller
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-02
- Primary completion
- 2025-01-16
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.